Regen BioPharma Declares Preferred Stock Dividend to All Shareholders

summarizeSummary

Regen BioPharma's Board of Directors declared a dividend of one share of Series A Preferred Stock for every share of common and existing preferred stock held, to be paid on or about February 9, 2026.

check_boxKey Events

• Preferred Stock Dividend Declared

  The Board of Directors declared a dividend payable in shares of the company's authorized but unissued Series A Preferred Stock.

• Distribution Ratio

  Shareholders will receive one share of Series A Preferred Stock for every one share of Common Stock, Series A Preferred, Series AA Preferred, Series M Preferred, and Series NC Preferred Stock owned.

• Record and Payment Dates

  The dividend is for shareholders of record as of February 3, 2026, and will be paid on or about February 9, 2026.

auto_awesomeAnalysis

Regen BioPharma's decision to issue a dividend of Series A Preferred Stock to all shareholders is a notable capital event for a micro-cap company. While not a cash dividend, it alters the company's capital structure by introducing a new class of preferred shares into circulation. This move could be a precursor to future financing activities, a strategic maneuver to distribute value without depleting cash reserves, or a way to prepare for potential corporate actions. Investors should monitor how these new preferred shares are valued and if their issuance signals any upcoming strategic initiatives or changes in corporate control.